These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17656357)

  • 1. Phosphatase activity, trimerization, and the C-terminal polybasic region are all required for PRL1-mediated cell growth and migration.
    Sun JP; Luo Y; Yu X; Wang WQ; Zhou B; Liang F; Zhang ZY
    J Biol Chem; 2007 Sep; 282(39):29043-29051. PubMed ID: 17656357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PRL1 promotes cell migration and invasion by increasing MMP2 and MMP9 expression through Src and ERK1/2 pathways.
    Luo Y; Liang F; Zhang ZY
    Biochemistry; 2009 Mar; 48(8):1838-46. PubMed ID: 19199380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of PRL1 as a novel diagnostic and therapeutic target for castration-resistant prostate cancer by the Escherichia coli ampicillin secretion trap (CAST) method.
    Shinmei S; Sentani K; Hayashi T; Sakamoto N; Goto K; Oo HZ; Naito Y; Teishima J; Matsubara A; Oue N; Kuniyasu H; Yasui W
    Urol Oncol; 2014 Aug; 32(6):769-78. PubMed ID: 24968948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PRL1 and PRL3 promote macropinocytosis via its lipid phosphatase activity.
    Ye Z; Ng CP; Liu H; Bao Q; Xu S; Zu D; He Y; Huang Y; Al-Aidaroos AQO; Guo K; Li J; Yaw LP; Xiong Q; Thura M; Zheng W; Guan F; Cheng X; Shi Y; Zeng Q
    Theranostics; 2024; 14(9):3423-3438. PubMed ID: 38948056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery and Evaluation of PRL Trimer Disruptors for Novel Anticancer Agents.
    Bai Y; Yu ZH; Zhang ZY
    Methods Mol Biol; 2016; 1447():121-38. PubMed ID: 27514804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-26a inhibits cell proliferation and invasion of cervical cancer cells by targeting protein tyrosine phosphatase type IVA 1.
    Dong J; Sui L; Wang Q; Chen M; Sun H
    Mol Med Rep; 2014 Sep; 10(3):1426-32. PubMed ID: 24939702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure and biochemical properties of PRL-1, a phosphatase implicated in cell growth, differentiation, and tumor invasion.
    Sun JP; Wang WQ; Yang H; Liu S; Liang F; Fedorov AA; Almo SC; Zhang ZY
    Biochemistry; 2005 Sep; 44(36):12009-21. PubMed ID: 16142898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of the PRL phosphatases.
    Rios P; Li X; Köhn M
    FEBS J; 2013 Jan; 280(2):505-24. PubMed ID: 22413991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Anticancer Agents Based on Targeting the Trimer Interface of the PRL Phosphatase.
    Bai Y; Yu ZH; Liu S; Zhang L; Zhang RY; Zeng LF; Zhang S; Zhang ZY
    Cancer Res; 2016 Aug; 76(16):4805-15. PubMed ID: 27325652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme activity of phosphatase of regenerating liver is controlled by the redox environment and its C-terminal residues.
    Skinner AL; Vartia AA; Williams TD; Laurence JS
    Biochemistry; 2009 May; 48(20):4262-72. PubMed ID: 19341304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphatase of regenerating liver-3 localizes to cyto-membrane and is required for B16F1 melanoma cell metastasis in vitro and in vivo.
    Song R; Qian F; Li YP; Sheng X; Cao SX; Xu Q
    PLoS One; 2009; 4(2):e4450. PubMed ID: 19214221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility.
    Fiordalisi JJ; Keller PJ; Cox AD
    Cancer Res; 2006 Mar; 66(6):3153-61. PubMed ID: 16540666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical role of protein of regenerating liver (PRL) phosphatases in ovarian carcinoma.
    Reich R; Hadar S; Davidson B
    Int J Mol Sci; 2011 Feb; 12(2):1133-45. PubMed ID: 21541048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metastasis-promoting phosphatase PRL-3 shows activity toward phosphoinositides.
    McParland V; Varsano G; Li X; Thornton J; Baby J; Aravind A; Meyer C; Pavic K; Rios P; Köhn M
    Biochemistry; 2011 Sep; 50(35):7579-90. PubMed ID: 21806020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PRL-1 tyrosine phosphatase regulates c-Src levels, adherence, and invasion in human lung cancer cells.
    Achiwa H; Lazo JS
    Cancer Res; 2007 Jan; 67(2):643-50. PubMed ID: 17234774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The essential role of FKBP38 in regulating phosphatase of regenerating liver 3 (PRL-3) protein stability.
    Choi MS; Min SH; Jung H; Lee JD; Lee TH; Lee HK; Yoo OJ
    Biochem Biophys Res Commun; 2011 Mar; 406(2):305-9. PubMed ID: 21320469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting PRL phosphatases in hematological malignancies.
    Xiao S; Chen H; Bai Y; Zhang ZY; Liu Y
    Expert Opin Ther Targets; 2024 Apr; 28(4):259-271. PubMed ID: 38653737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thioredoxin-related protein 32 (TRP32) specifically reduces oxidized phosphatase of regenerating liver (PRL).
    Ishii T; Funato Y; Miki H
    J Biol Chem; 2013 Mar; 288(10):7263-70. PubMed ID: 23362275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of phosphatase regenerating liver 3 in oesophageal squamous cell carcinoma associated with metastasis and its comparison with phosphatase regenerating liver 1.
    Lou X; Liu Y; Lei JY; Li H
    Cell Biol Int; 2012 Aug; 36(8):759-63. PubMed ID: 22551255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of phosphatase of regenerating liver 1 (PRL1) in spermatogenesis.
    Bai Y; Zhou HM; Zhang L; Dong Y; Zeng Q; Shou W; Zhang ZY
    Sci Rep; 2016 Sep; 6():34211. PubMed ID: 27666520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.